Kopran Limited Share Price & Analysis
₹189.08▲ +2.72%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹189.08
+2.72%
Open
₹—
High
₹193
Low
₹179
Close
₹189.08
52W High
₹219
52W Low
₹107
Volume
175K
Lot Size
1
Sector
Healthcare
Market Cap
₹946 Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
36.8
Sector P/E
48.9
P/B
1.72
EPS
₹3.43
ROE
4.91%
ROCE
6.65%
D/E Ratio
0.29
Div Yield
1.53%
Book Value
₹110
+
Strengths
- ✓Attractively valued vs sector (P/E 36.8x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.3x)
- ✓Regular dividends — yield 1.5%
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
KOPRAN · as of Mar 2026
Promoters44.42%▼0.03
FII1.11%▲0.25
Public54.45%▼0.23
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 44.49% | 44.49% | 44.49% | 44.49% | 44.45% | 44.42% |
| FII | 0.48% | 0.84% | 0.68% | 1.31% | 0.86% | 1.11% |
| DII | 0.14% | 1.20% | 0.14% | 0.22% | — | — |
| Public | 54.88% | 53.47% | 54.68% | 53.98% | 54.68% | 54.45% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend18 May 2026
Dividend - Rs 3 Per Share
Dividend3 Sept 2025
Annual General Meeting/Dividend - Rs 3 Per Share
Dividend1 Sept 2024
Annual General Meeting/Dividend - Rs 3 Per Share
Dividend6 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹194 Cr ▲64.4% | ₹118 Cr ▼12.6% | ₹135 Cr ▼21.5% | ₹172 Cr ▲3.6% | ₹166 Cr ▲9.2% | ₹152 Cr ▲9.4% | ₹139 Cr ▼25.3% | ₹186.08 Cr |
| Op. Profit | ₹18 Cr ▲460.0% | ₹-5 Cr ▼135.7% | ₹14 Cr ▼17.6% | ₹17 Cr ▼15.0% | ₹20 Cr ▲33.3% | ₹15 Cr ▼16.7% | ₹18 Cr ▼17.0% | ₹21.69 Cr |
| OPM | 9.0% ▲325.0% | -4.0% ▼140.0% | 10.0% ▲0.0% | 10.0% ▼16.7% | 12.0% ▲20.0% | 10.0% ▼23.1% | 13.0% ▲11.5% | 11.7% |
| Net Profit | ₹9 Cr ▲190.0% | ₹-10 Cr ▼242.9% | ₹7 Cr ▼30.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲42.9% | ₹7 Cr ▼36.4% | ₹11 Cr ▼40.9% | ₹18.62 Cr |
| EPS (₹) | 1.94 ▲194.2% | -2.06 ▼233.8% | 1.54 ▼23.4% | 2.01 ▼6.9% | 2.16 ▲41.2% | 1.53 ▼33.5% | 2.3 ▼40.4% | 3.86 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹681 Cr ▲8.1% | ₹630 Cr ▲2.4% | ₹615 Cr ▲11.6% | ₹551 Cr ▲15.3% | ₹478 Cr ▼2.8% | ₹492 Cr ▲36.7% | ₹360 Cr ▲0.6% | ₹358 Cr ▲14.4% | ₹313 Cr ▲1.0% | ₹310 Cr |
| Expenses | ₹619 Cr ▲11.1% | ₹557 Cr ▲3.1% | ₹540 Cr ▲8.2% | ₹499 Cr ▲27.9% | ₹390 Cr ▼4.9% | ₹410 Cr ▲31.0% | ₹313 Cr ▲0.3% | ₹312 Cr ▲10.2% | ₹283 Cr ▲3.3% | ₹274 Cr |
| Op. Profit | ₹62 Cr ▼15.1% | ₹73 Cr ▼1.4% | ₹74 Cr ▲42.3% | ₹52 Cr ▼40.2% | ₹87 Cr ▲6.1% | ₹82 Cr ▲74.5% | ₹47 Cr ▲2.2% | ₹46 Cr ▲48.4% | ₹31 Cr ▼13.9% | ₹36 Cr |
| OPM | 9.0% ▼25.0% | 12.0% ▲0.0% | 12.0% ▲33.3% | 9.0% ▼50.0% | 18.0% ▲5.9% | 17.0% ▲30.8% | 13.0% ▲0.0% | 13.0% ▲30.0% | 10.0% ▼16.7% | 12.0% |
| Other Income | ₹0 Cr ▼100.0% | ₹4 Cr ▼73.3% | ₹15 Cr ▲400.0% | ₹3 Cr ▼72.7% | ₹11 Cr ▼38.9% | ₹18 Cr | ₹0 Cr ▼100.0% | ₹3 Cr ▼66.7% | ₹9 Cr ▼18.2% | ₹11 Cr |
| Interest | ₹10 Cr ▲11.1% | ₹9 Cr ▲0.0% | ₹9 Cr ▲50.0% | ₹6 Cr ▲20.0% | ₹5 Cr ▼16.7% | ₹6 Cr ▼33.3% | ₹9 Cr ▲0.0% | ₹9 Cr ▲0.0% | ₹9 Cr ▼35.7% | ₹14 Cr |
| Depreciation | ₹17 Cr ▲6.3% | ₹16 Cr ▲23.1% | ₹13 Cr ▲0.0% | ₹13 Cr ▲18.2% | ₹11 Cr ▲10.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲11.1% | ₹9 Cr ▲0.0% | ₹9 Cr ▲12.5% | ₹8 Cr |
| PBT | ₹34 Cr ▼34.6% | ₹52 Cr ▼23.5% | ₹68 Cr ▲88.9% | ₹36 Cr ▼56.1% | ₹82 Cr ▼1.2% | ₹83 Cr ▲196.4% | ₹28 Cr ▼12.5% | ₹32 Cr ▲39.1% | ₹23 Cr ▼8.0% | ₹25 Cr |
| Tax % | 25.0% ▼3.8% | 26.0% ▲4.0% | 25.0% ▲4.2% | 24.0% ▼4.0% | 25.0% ▼3.8% | 26.0% ▲0.0% | 26.0% ▲8.3% | 24.0% ▲140.0% | 10.0% ▼50.0% | 20.0% |
| Net Profit | ₹26 Cr ▼33.3% | ₹39 Cr ▼23.5% | ₹51 Cr ▲88.9% | ₹27 Cr ▼55.7% | ₹61 Cr ▼1.6% | ₹62 Cr ▲195.2% | ₹21 Cr ▼12.5% | ₹24 Cr ▲20.0% | ₹20 Cr ▲0.0% | ₹20 Cr |
| EPS (₹) | 5.33 ▼33.3% | 7.99 ▼24.4% | 10.57 ▲87.1% | 5.65 ▼55.4% | 12.66 ▼11.1% | 14.24 ▲193.0% | 4.86 ▼12.4% | 5.55 ▲17.1% | 4.74 ▲3.0% | 4.6 |
| Div Payout | 0.0% ▼100.0% | 38.0% ▲35.7% | 28.0% ▼47.2% | 53.0% ▲120.8% | 24.0% ▲14.3% | 21.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹48 Cr ▲0.0% | ₹48 Cr ▲0.0% | ₹48 Cr ▲0.0% | ₹48 Cr ▲0.0% | ₹48 Cr ▲11.6% | ₹43 Cr ▲0.0% | ₹43 Cr ▲0.0% | ₹43 Cr ▲0.0% | ₹43 Cr ▲0.0% | ₹43 Cr |
| Reserves | ₹453 Cr ▼3.6% | ₹470 Cr ▲6.1% | ₹443 Cr ▲13.3% | ₹391 Cr ▲3.4% | ₹378 Cr ▲87.1% | ₹202 Cr ▲38.4% | ₹146 Cr ▲16.8% | ₹125 Cr ▲23.8% | ₹101 Cr ▲24.7% | ₹81 Cr |
| Borrowings | ₹157 Cr ▲6.1% | ₹148 Cr ▲49.5% | ₹99 Cr ▲32.0% | ₹75 Cr ▲0.0% | ₹75 Cr ▲13.6% | ₹66 Cr ▼25.0% | ₹88 Cr ▼9.3% | ₹97 Cr ▲9.0% | ₹89 Cr ▼6.3% | ₹95 Cr |
| Other Liabilities | ₹155 Cr ▼12.9% | ₹178 Cr ▲16.3% | ₹153 Cr ▲13.3% | ₹135 Cr ▲22.7% | ₹110 Cr ▼14.1% | ₹128 Cr ▲39.1% | ₹92 Cr ▲8.2% | ₹85 Cr ▲3.7% | ₹82 Cr ▲5.1% | ₹78 Cr |
| Total Liabilities | ₹813 Cr ▼3.7% | ₹844 Cr ▲13.6% | ₹743 Cr ▲14.3% | ₹650 Cr ▲6.4% | ₹611 Cr ▲39.2% | ₹439 Cr ▲18.6% | ₹370 Cr ▲5.4% | ₹351 Cr ▲11.4% | ₹315 Cr ▲5.7% | ₹298 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹235 Cr ▲13.0% | ₹208 Cr ▲14.3% | ₹182 Cr ▲10.3% | ₹165 Cr ▲9.3% | ₹151 Cr ▲34.8% | ₹112 Cr ▲0.9% | ₹111 Cr ▼1.8% | ₹113 Cr ▲8.7% | ₹104 Cr ▲0.0% | ₹104 Cr |
| CWIP | ₹114 Cr ▲0.9% | ₹113 Cr ▲16.5% | ₹97 Cr ▲38.6% | ₹70 Cr ▲94.4% | ₹36 Cr ▼16.3% | ₹43 Cr ▲43.3% | ₹30 Cr ▲25.0% | ₹24 Cr ▲140.0% | ₹10 Cr ▲66.7% | ₹6 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹465 Cr ▼10.9% | ₹522 Cr ▲12.3% | ₹465 Cr ▲12.0% | ₹415 Cr ▼2.4% | ₹425 Cr ▲49.6% | ₹284 Cr ▲24.0% | ₹229 Cr ▲7.0% | ₹214 Cr ▲6.5% | ₹201 Cr ▲7.5% | ₹187 Cr |
| Total Assets | ₹813 Cr ▼3.7% | ₹844 Cr ▲13.6% | ₹743 Cr ▲14.3% | ₹650 Cr ▲6.4% | ₹611 Cr ▲39.2% | ₹439 Cr ▲18.6% | ₹370 Cr ▲5.4% | ₹351 Cr ▲11.4% | ₹315 Cr ▲5.7% | ₹298 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹42 Cr ▼2.3% | ₹43 Cr ▲26.5% | ₹34 Cr ▲203.0% | ₹-33 Cr ▼155.0% | ₹60 Cr ▲93.5% | ₹31 Cr ▲24.0% | ₹25 Cr ▼3.8% | ₹26 Cr ▲62.5% | ₹16 Cr ▼44.8% | ₹29 Cr |
| Investing CF | ₹-56 Cr ▼27.3% | ₹-44 Cr ▼238.5% | ₹-13 Cr ▲84.5% | ₹-84 Cr ▼236.0% | ₹-25 Cr ▼92.3% | ₹-13 Cr ▲48.0% | ₹-25 Cr ▼127.3% | ₹-11 Cr ▲38.9% | ₹-18 Cr ▼100.0% | ₹-9 Cr |
| Financing CF | ₹26 Cr ▲2500.0% | ₹1 Cr ▲105.0% | ₹-20 Cr ▼116.3% | ₹123 Cr ▲451.4% | ₹-35 Cr ▼94.4% | ₹-18 Cr ▼1700.0% | ₹-1 Cr ▲93.3% | ₹-15 Cr ▼850.0% | ₹2 Cr ▲110.5% | ₹-19 Cr |
| Net Cash Flow | ₹11 Cr ▲1000.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▼60.0% | ₹5 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹-17 Cr ▼30.8% | ₹-13 Cr ▲51.9% | ₹-27 Cr ▲64.5% | ₹-76 Cr ▼276.7% | ₹43 Cr ▲152.9% | ₹17 Cr ▲383.3% | ₹-6 Cr ▼142.9% | ₹14 Cr | ₹0 Cr ▼100.0% | ₹18 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125d ▼0.8% | 126d ▲16.7% | 108d ▲11.3% | 97d ▲9.0% | 89d ▼5.3% | 94d ▲6.8% | 88d ▲17.3% | 75d ▼12.8% | 86d ▲22.9% | 70d |
| Inventory Days | 153d ▲21.4% | 126d ▼5.3% | 133d ▼34.2% | 202d ▲66.9% | 121d ▼21.4% | 154d ▲19.4% | 129d ▼6.5% | 138d ▲13.1% | 122d ▲2.5% | 119d |
| Days Payable | 108d ▲4.9% | 103d ▲15.7% | 89d ▲6.0% | 84d ▼19.2% | 104d ▲9.5% | 95d ▲5.6% | 90d ▼23.7% | 118d ▲24.2% | 95d ▼17.4% | 115d |
| Cash Conv. Cycle | 170d ▲14.1% | 149d ▼2.0% | 152d ▼29.3% | 215d ▲102.8% | 106d ▼30.7% | 153d ▲20.5% | 127d ▲32.3% | 96d ▼15.0% | 113d ▲52.7% | 74d |
| Working Capital Days | 113d ▼13.7% | 131d ▼5.8% | 139d ▼12.0% | 158d ▲95.1% | 81d ▲2.5% | 79d ▲12.9% | 70d ▲16.7% | 60d ▲39.5% | 43d ▲26.5% | 34d |
| ROCE | 10.0% ▼28.6% | 14.0% ▲75.0% | 8.0% ▼61.9% | 21.0% ▼30.0% | 30.0% ▲114.3% | 14.0% ▼12.5% | 16.0% ▲14.3% | 14.0% ▼26.3% | 19.0% ▲35.7% | 14.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Kopran Limited share price today?▾
Kopran Limited (KOPRAN) is currently trading at ₹189.08 on NSE, up 2.72% as of the last market session. Prices update daily after market close on MarketNetra.
Is Kopran Limited available in F&O (Futures & Options)?▾
Yes, Kopran Limited (KOPRAN) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Kopran Limited 52-week high and low?▾
Kopran Limited's 52-week high is ₹219 and the 52-week low is ₹107. The current price of ₹189.08 is 13.7% below the 52W high.
What is Kopran Limited P/E ratio?▾
Kopran Limited's current P/E ratio is 36.8. This indicates the market is paying ₹36.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Kopran Limited options?▾
Kopran Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade KOPRAN options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.